PRODUCT LITERATURE

Clinical Safety and Efficacy of Clopidogrel-Implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) Study for Future Management of Atherosclerotic Disease

---

Clopidogrel is a new antiplatelet agent that has recently been approved in the United States for the reduction of atherosclerotic
events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent
stroke, recent myocardial infarction, or established peripheral arterial disease (PAD).

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Vaclo

Specific Detail Info

CLINICAL THERAPEVMCSVVOL. 20, SUPPLEMENT B, 1998

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment